Handling AI is like dealing with “a real and mysterious creature, not a predictable machine,” said Jack Clark, co-founder of Anthropic, at a Berkeley conference.
The FDA announced the first batch of drugs that will receive expedited reviews under the Commissioner’s National Priority Voucher (CNPV) pilot program.
